LANE WAGNON: Open Payments
NPI 1871756395 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 49 payments from 10 companies in 2025. Trend: 2023 $1,196 · 2024 $906 · 2025 $913
Food & beverage: $913
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $164 |
| AstraZeneca Pharmaceuticals LP | 5 | $135 |
| Merck Sharp & Dohme LLC | 8 | $135 |
| Actelion Pharmaceuticals US, Inc. | 6 | $132 |
| BridgeBio Pharma, Inc. | 5 | $88 |
| Novartis Pharmaceuticals Corporation | 5 | $86 |
| Novo Nordisk Inc | 5 | $82 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Philips North America LLC | 1 | $17 |
Products named: ELIQUIS, FARXIGA, VERQUVO, Attruby, LEQVIO, Wegovy, OPSUMIT, VYNDAQEL.
Industry payments across AR — which companies pay providers there.
